Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput

Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput

The current drug development pipeline takes approximately fifteen years and $2.6 billion to get a new drug to market. Typically, drugs are tested on two-dimensional (2D) cell cultures and animal models to estimate their efficacy before reaching human trials. However, these models are often not repre...

Full description

Bibliographic Details
Main Authors: Erin Maloney, Casey Clark, Hemamylammal Sivakumar, KyungMin Yoo, Julio Aleman, Shiny A. P. Rajan, Steven Forsythe, Andrea Mazzocchi, Adrian W. Laxton, Stephen B. Tatter, Roy E. Strowd, Konstantinos I. Votanopoulos, Aleksander Skardal
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Micromachines
Subjects:
bioprinting
bioink
extracellular matrix
cancer
organoid
drug screening
personalized medicine
Online Access:https://www.mdpi.com/2072-666X/11/2/208

Internet

https://www.mdpi.com/2072-666X/11/2/208

Similar Items